Renal and Vascular Pathologies

A novel potent vasoconstrictor peptide produced by vascular endothelial cells

Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes

Angiogenesis in cancer, vascular, rheumatoid and other disease

Effects of Losartan on Renal and Cardiovascular Outcomes in Patients with Type 2 Diabetes and Nephropathy

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein

Intensive Blood Glucose Control and Vascular Outcomes in Patients with Type 2 Diabetes

Acute renal failure – definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group

Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy

Nivolumab versus Everolimus in Advanced Renal-Cell Carcinoma

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19

An RNA-Sequencing Transcriptome and Splicing Database of Glia, Neurons, and Vascular Cells of the Cerebral Cortex

A Quantitative Assessment of Plasma Homocysteine as a Risk Factor for Vascular Disease

Using Standardized Serum Creatinine Values in the Modification of Diet in Renal Disease Study Equation for Estimating Glomerular Filtration Rate

Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure

Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

Sorafenib in Advanced Clear-Cell Renal-Cell Carcinoma